Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) EBIT Margin (2020 - 2025)

Celularity (CELU) has disclosed EBIT Margin for 6 consecutive years, with 486.89% as the latest value for Q4 2025.

  • For Q4 2025, EBIT Margin rose 183573.0% year-over-year to 486.89%; the TTM value through Dec 2025 reached 72.57%, up 3173.0%, while the annual FY2025 figure was 72.57%, 183.0% down from the prior year.
  • EBIT Margin hit 486.89% in Q4 2025 for Celularity, up from 244.13% in the prior quarter.
  • Across five years, EBIT Margin topped out at 486.89% in Q4 2025 and bottomed at 2621.66% in Q3 2023.
  • Average EBIT Margin over 5 years is 569.35%, with a median of 190.34% recorded in 2022.
  • Year-over-year, EBIT Margin tumbled -248512bps in 2023 and then surged 249766bps in 2024.
  • Celularity's EBIT Margin stood at 307.89% in 2021, then soared by 238bps to 423.47% in 2022, then plummeted by -74bps to 109.93% in 2023, then crashed by -1327bps to 1348.84% in 2024, then skyrocketed by 136bps to 486.89% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 486.89%, 244.13%, and 276.57% for Q4 2025, Q3 2025, and Q2 2025 respectively.